Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2021-12-07 2021-12-07
Drug Identification Number 02249561 02249561
Brand name FLUMAZENIL INJECTION FLUMAZENIL INJECTION
Common or Proper name FLUMAZENIL FLUMAZENIL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients FLUMAZENIL FLUMAZENIL
Strength(s) 0.1MG 0.1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5ML10LIVI 5ML10LIVI
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-04 2021-10-04
Estimated end date 2021-12-10 2021-12-10
Actual end date 2021-12-06 2021-12-06
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments